craving sugar on tirzepatide Impact of treatment participant‐reported food and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction - Kennedy Tirzepatide Mechanism of Weight Loss

Tirzepatide was on the FDA drug shortage list for an extended period as demand for Mounjaro and Zepbound far exceeded manufacturing capacity

After removing 1,142 duplicates, 2,390 records were screened

Patients on Wegovy HD lost an average of 20.7% of body weight over 72 weeks, compared with 17.5% on Wegovy 2.4 mg

Gastrite, reflusso gastroesofageo, bruciore di stomaco

Obesity increases the risk of prediabetes and type 2 diabetes

2.1.1 Monoamine transporter disruption and neurotransmitter release METH disrupts the reuptake and enhances the release of dopamine, serotonin, and norepinephrine, significantly increasing their extracellular concentrations